LUCD - Lucid Diagnostics Inc.

QQQ $ 419.96 $ -1.06 (-0.25 %)

DIA $ 384.57 $ -0.58 (-0.15 %)

SPY $ 502.26 $ 0.00 (0 %)

TLT $ 87.74 $ -0.19 (-0.22 %)

GLD $ 215.69 $ 0.35 (0.16 %)

Previous Close

$ 0.6831

Open

$ 0.71

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.68 - $ 0.71

52 Week Range

$ 0.67 - $ 1.85

Volume

236,067

Average Volume

Market Cap

28.52M

Beta (5Y Monthly)

$ 1.30

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-25-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-14-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	04-06-2022	12-31-2021	10-K
10	11-23-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Lucid Diagnostic...
04/12/2024 08:37:23

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

Cantor Fitzgerald Maintains Overweight on ...
03/27/2024 14:05:45

Cantor Fitzgerald analyst Ross Osborn maintains Lucid Diagnostics (NASDAQ:LUCD) with a Overweight and lowers the price targe...

Needham Reiterates Buy on Lucid Diagnostic...
03/27/2024 09:20:42

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

Lucid Diagnostics Q4 EPS $(0.23) Beats $(0...
03/25/2024 21:43:59

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0...

Lucid Diagnostics Provides Business Update...
03/25/2024 21:33:22

Lucid Diagnostics had cash and cash equivalents of $18.9 million as of December 31, 2023, compared to $22.5 million as of Decem...

Earnings Scheduled For March 25, 2024
03/25/2024 09:33:46

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

Earnings Preview: Lucid Diagnostics
03/22/2024 14:01:32

Lucid Diagnostics Announces Data From The ...
03/21/2024 13:31:09

Prospective VA screening study demonstrates excellent EsoGuard sensitivity of 92.9% and negative predictive value of 98.6% comp...

Lucid Diagnostics Announces Multiple Prese...
03/20/2024 12:44:32

Lucid and collaborators will present data on three studies on EsoGuard® esophageal precancer testing and one on a new genetic c...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
02/19/2024 21:30:44

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

Lucid Diagnostics Announces Peer-Reviewed ...
12/12/2023 13:31:27

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical ...

PAVmed Provides Additional Details For Upc...
12/11/2023 14:18:46

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common...

PAVmed Shareholders As Of January 15, 2024...
12/04/2023 21:29:37

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common...

On November 27, 2023, Lucid Diagnostics Re...
11/28/2023 21:36:18

Lucid Diagnostics Strengthens And Expands ...
11/16/2023 14:14:32

Industry veterans join executive team as VP, Market Access and VP, Employer MarketsShaun M. O'Neil promoted to Lucid's ...

Needham Maintains Buy on Lucid Diagnostics...
11/14/2023 18:43:14

Needham analyst Mike Matson maintains Lucid Diagnostics (NASDAQ:LUCD) with a Buy and lowers the price target from $2.8 to $2.5.

Lucid Diagnostics Q3 Adj EPS $(0.22) Beats...
11/13/2023 22:54:06

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

Lucid Diagnostics Q3 EPS $(0.22) Beats $(0...
11/13/2023 22:45:04

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

Lucid Diagnostics Reports Q3 EsoGuard Reve...
11/13/2023 22:44:15

Lucid had cash and cash equivalents of $24.1 million as of September 30, 2023, compared to $32.6 million as of June 30, 2023.